Size of creutzfeldt-jakob disease epidemic associated with cadaveric dura transplantation

Neuroepidemiology

Volumn 34, Issue 4, 2010, Pages 232-237

  Tanaka, Shiro ^a   Fukushima, Masanori ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cadaveric dura mater; Creutzfeldt Jakob disease; Incubation period; Japan; Prion disease; Projection

Indexed keywords

ADULT; ARTICLE; BAYES THEOREM; CADAVER; CREUTZFELDT JAKOB DISEASE; DURA MATER; EPIDEMIC; EPIDEMIOLOGICAL DATA; EXPOSURE; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PROBABILITY; PUBLIC HEALTH SERVICE; TISSUE TRANSPLANTATION;

CREUTZFELDT-JAKOB SYNDROME; DISEASE OUTBREAKS; DURA MATER; HUMANS; IATROGENIC DISEASE; JAPAN; MODELS, STATISTICAL; ORGAN TRANSPLANTATION; POPULATION SURVEILLANCE;

EID: 77952355150     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000297747     Document Type: Article

References (18)

1. Janssen RS, Schönberger LB: Creutzfeldt-Jakob disease from allogeneic dura: a review of risks and safety. J Oral Maxillofac Surg 1991;49:274-275.
2. Centers for Disease Control (CDC): Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR Morb Mortal Wkly Rep 1987;36:49-50.
3. Centers for Disease Control (CDC): Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts: Japan, January 1979-May 1996. MMWR Morb Mortal Wkly Rep 1997;46:1066-1069.
4. Brown P, Preece M, Brandel JP, et al: Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-1081.
5. Brown P, Brandel JP, Preese M, Sato T: Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006;67:389-393.
6. Centers for Disease Control (CDC): Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, 1978-2008. MMWR Morb Mortal Wkly Rep 2008; 57:1152-1154.
7. Triendl R: CJD link prompts ban on brain tissue use. Nature 1997;387:5.
8. Nakamura Y, Yanagawa H, Hoshi K, et al: Incidence rate of Creutzfeldt-Jakob disease in Japan. Int J Epidemiol 1999;28:130-134.
9. Nakamura Y, Aso E, Yanagawa H: Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan. Neurol-og y 1999;53:218-220.
10. Hamada C, Sadaike T, Fukushima M: Projection of Creutzfeldt-Jakob disease frequency based on cadaveric dura transplantation in Japan. Neuroepidemiology 2003;22:57-64.
11. Lui KJ, Darrow WW, Rutherford GW: A model-based estimate of the mean incubation period for AIDS in homosexual men. Science 1988;24:1333-1335.
12. Hoshi K, Yoshino H, Urata J, et al: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 2000;55:718-721.
13. Hannah EL, Belay ED, Gambetti P, et al: Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 2001;56:1080-1083.
14. Greenland S: Sensitivity analysis, Monte Carlo risk analysis, and bayesian uncertainty assessment. Risk Anal 2005;21:579-584.
15. Huillard d'Aignaux JN, Costagliola D, Maccario J, et al: Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999;53:1197.
16. Klitzman RL, Alpers MP, Gajdusek DC: The natural incubation period of kuru and the episodes of transmission in three clusters of patients. Neuroepidemiology 1984;3:3-20.
17. Brookmeyer RL, Gail MH: AIDS Epidemiology. New York, Oxford University Press, 1994.
18. Boëlle PY, Thomas G, Valleron AJ, Cesbron JY, Will R: Modelling the epidemic of variant Creutzfeldt-Jakob disease in the UK based on age characteristics: updated, detailed analysis. Stat Methods Med Res 2003;12:221-233.